07/18/2025 |  | 2025 Persistent Myocardial Fibrosis in CHF |
Michael Zile, MD
| 08/08/2025 |
07/18/2025 |  | Panel Discussion: How Do We Continue & Speed Up The Current Progress That Has Been Made In The Treatment Of HFpEF Over The Past Decade? |
Ryan Tedford, M.D Sheldon Litwin, M.D. Daniel Silverman, M.D. Michael Zile, M.D.
| 08/08/2025 |
07/18/2025 |  | Phenotyping HFpEF: How Do We Make It Clinically Relevant? |
Vishal Rao, M.D.
| 08/08/2025 |
07/18/2025 |  | Etiology, Evaluation, and Management of Iron Deficiency in Heart Failure |
Gregory Lewis, M.D
| 08/08/2025 |
07/18/2025 |  | Perils and Pearls of Polypharmacy in HFpEF |
Parag Goyal MD, MSc
| 08/08/2025 |
07/18/2025 |  | The Emerging Role of Device Therapies in HFpEF |
Michele Esposito, M.D
| 08/08/2025 |
07/18/2025 |  | Top HFpEF Papers of the Year |
Ryan Tedford, M.D.
| 08/08/2025 |
07/18/2025 |  | Should we be Performing Heart Transplantation for HFpEF? |
Jeffrey Teuteberg, MD
| 08/08/2025 |
07/18/2025 |  | From Inflammation to Dysfunction: Autoimmune Disease as a Substrate for HFpEF |
Monica Mukherjee, M.D.
| 08/08/2025 |